BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1531219)

  • 1. Kinetic uptake of etanidazole in lung carcinoma and normal tissue in vivo.
    Busutti L; Breccia A; Ferri E; Falcone F; Bertoni F
    Int J Radiat Oncol Biol Phys; 1992; 22(3):585-8. PubMed ID: 1531219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience.
    Lee DJ; Phillips TL; Coleman CN; Cosmatos D; Davis LW; Wasserman TH; Marcial VA; Rubin P
    Int J Radiat Oncol Biol Phys; 1992; 22(3):569-71. PubMed ID: 1531215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
    Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):703-8. PubMed ID: 1825993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer: evidence of diffusion from urine.
    Awwad HK; el Badawy S; abd el Baki H; Zaghloul M; el Moneim Osman A; Akoush H; Fairchild K
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1083-4. PubMed ID: 2522918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of etanidazole into human brain tumors: implications for treating high grade gliomas.
    Hurwitz SJ; Coleman CN; Riese N; Loeffler JS; Alexander E; Buswell L; Neben TY; Shargel L; Kramer RA
    Int J Radiat Oncol Biol Phys; 1992; 22(3):573-6. PubMed ID: 1531216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Bleehen NM; Ward R; Workman P
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study.
    Bleehen NM; Maughan TS; Workman P; Newman HF; Stenning S; Ward R
    Radiother Oncol; 1991; 20 Suppl 1():137-42. PubMed ID: 1826962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Ward R; Workman P; Bleehen NM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First analysis of tumor regression for the European randomized trial of etanidazole combined with radiotherapy in head and neck carcinomas.
    Chassagne D; Charreau I; Sancho-Garnier H; Eschwege F; Malaise EP
    Int J Radiat Oncol Biol Phys; 1992; 22(3):581-4. PubMed ID: 1531218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors.
    Stone HB; Hirst VK; Cribbs R; Luu YH; Brown JM
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study.
    Coleman CN; Noll L; Howes AE; Harris JR; Zakar J; Kramer RA
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1085-7. PubMed ID: 2522919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
    Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
    Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
    Coleman CN; Buswell L; Noll L; Riese N; Rose MA
    Int J Radiat Oncol Biol Phys; 1992; 22(3):565-8. PubMed ID: 1310497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combination.
    Workman P
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1011-4. PubMed ID: 2522916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole and radiotherapy in lung cancer: a randomized double-blind trial.
    Mäntylä MJ; Nordman EM; Ruotsalainen PJ; Kylmämaa TT
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1719-20. PubMed ID: 6759478
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508).
    Maughan TS; Newman HF; Bleehen NM; Ward R; Workman P
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1151-6. PubMed ID: 2140825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.